Become A Featured Company

Northstar Global Partners to Develop New Cannabis Product Line

Ryan Allway

March 11th, 2014

News, Top Story

Northstar Global Business Services, Inc. (OTC: MDIN), a company dedicated to producing the best alternative healthcare products to the world, recently announced partnerships with Dixie Elixirs and Kush Creams to develop cannabis products featuring its patented oral spray delivery system for such uses as a THC oral spray, and a THC and snoring solution. No release dates have currently been set for the product, although management appears to be very excited about the prospects. Northern Global’s stock is trading down more than 10% on average volume following the news.

Read the entire press release discussing the partnerships here:

Northstar Global Business Services, Inc., (OTC-PINK:MDIN) today announced that the company has begun to develop a new product line with the help of several top medical marijuana industry leaders like Dixie Elixirs, a marijuana manufacturer recently featured on 60 minutes, and Kush Creams, another marijuana product manufacturer who has received many awards for their excellency in producing medical marijuana products going back as far as 2008. Northstar management feels that by tapping into the leading sources in the business, the new product line will gain the experience and existing distribution network needed to quickly make the company a leader as well.

The new products being developed feature Northstar’s patented oral spray delivery system, for such uses as a THC oral spray, and a THC and snoring solution.  Since one of the most popular reasons patients are prescribed medical marijuana is for sleeping disorders, the products cover several bases at once giving patients one solution to several problems. Northstar also feels that a spray can be the most effective and safest delivery system for medical marijuana, but previous attempts by other companies to make an oral THC spray always fell short. However, by applying Northstar’s many years of experience with oral spray technology, the company feels it can use the oral spray effectively, and become the most popular delivery method for medical marijuana patients.

“We think our spray technology is the answer for THC delivery, and it seemed only natural that we partner with only the best in the business. We bring tremendous strengths to the table, and these strengths coupled with powerhouse marijuana product producers like Dixie Elixirs, Kush Creams and several others, make for an unstoppable combination in my opinion,” said company CEO, Nick Chieco.

Although, no release dates are currently set for any specific products, the company has very high expectations and feels that having a hand in one of the fastest growing industries in the world, will give Northstar an edge in both the medical marijuana and traditional alternative healthcare industries.

About Northstar
Northstar Global Business Services is dedicated to producing the best alternative healthcare products to the world. The company’s product line includes Snorenz®, Good Night’s Sleep®, Stem-Intense, and most recently in development is a line of medical marijuana oral sprays. Most of the company’s products use a unique or patented spray delivery system, and all have received rave consumer reviews all over the world, selling millions of units from 1996 to the present. More information can be found at www.medgeninc.com.

DISCLAIMER
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as “anticipates,” “believes,” “estimates,” “expects,” “plans,” “intends,” “potential” and similar expressions. These statements reflect the Company’s current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company’s actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.

SOURCE Northstar Global Business Services, Inc.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading